Hijacking complement regulatory proteins for bacterial immune evasion

Frontiers in Microbiology

Volumn 7, Issue DEC, 2016, Pages

  Hovingh, Elise S ^a,b   van den Broek, Bryan ^a   Jongerius, Ilse ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bacteria; Complement; Complement regulatory proteins; Immune evasion of bacteria; Vaccine development

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; CD59 ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; CLUSTERIN; COMPLEMENT; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; FACTOR H LIKE PROTEIN1; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MEMBRANE COFACTOR PROTEIN; REGULATOR PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; VITRONECTIN;

BACTERIAL INFECTION; BACTERIAL SURVIVAL; BORDETELLA; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; DRUG DESIGN; DRUG TARGETING; HOST; HUMAN; IMMUNE EVASION; MEMBRANE VESICLE; NONHUMAN; PHAGOCYTOSIS; REVIEW; STREPTOCOCCUS PNEUMONIAE; YERSINIA;

EID: 85008893432     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.02004     Document Type: Review

References (175)

1. Achila, D., Liu, A., Banerjee, R., Li, Y., Martinez-Hackert, E., Zhang, J. R., et al. (2015). Structural determinants of host specificity of complement factor H recruitment by Streptococcus pneumoniae. Biochem. J. 465, 325-335. doi: 10.1042/BJ20141069
2. Agarwal, V., Hammerschmidt, S., Malm, S., Bergmann, S., Riesbeck, K., and Blom, A. M. (2012). Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J. Immunol. 189, 3575-3584. doi: 10.4049/jimmunol.1102934
3. Al-Jubair, T., Mukherjee, O., Oosterhuis, S., Singh, B., Su, Y. C., Fleury, C., et al. (2015). Haemophilus influenzae Type f hijacks vitronectin using protein H to resist host innate immunity and adhere to pulmonary Epithelial Cells. J. Immunol. 195, 5688-5695. doi: 10.4049/jimmunol.1501197
4. Amdahl, H., Jongerius, I., Meri, T., Pasanen, T., Hyvärinen, S., Haapasalo, K., et al. (2013). Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion. J. Immunol. 191, 1775-1784. doi: 10.4049/jimmunol.1300638
5. Barilla-LaBarca, M. L., Liszewski, K. M., Lambris, J. D., Hourcade, D., and Atkinson, J. P. (2002). Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J. Immunol. 168, 6298-6304. doi: 10.4049/jimmunol.168.12.6298
6. Bartra, S. S., Styer, K. L., O'Bryant, D. M., Nilles, M. L., Hinnebusch, B. J., Aballay, A., et al. (2008). Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect. Immun. 76, 612-622. doi: 10.1128/IAI.01125-07
7. Berggård, K., Johnsson, E., Mooi, F. R., and Lindahl, G. (1997). Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect. Immun. 65, 3638-3643.
8. Berggård, K., Lindahl, G., Dahlbäck, B., and Blom, A. M. (2001). Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. Eur. J. Immunol. 31, 2771-2780. doi: 10.1002/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0
9. Bernet, J., Ahmad, M., Mullick, J., Panse, Y., Singh, A. K., Parab, P. B., et al. (2011). Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity. Vaccine 29, 7435-7443. doi: 10.1016/j.vaccine.2011.07.062
10. Bhattacharjee, A., Oeemig, J. S., Kolodziejczyk, R., Meri, T., Kajander, T., Lehtinen, M. J., et al. (2013). Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi. J. Biol. Chem. 288, 18685-18695. doi: 10.1074/jbc.M113.459040
11. Biagini, M., Spinsanti, M., De Angelis, G., Tomei, S., Ferlenghi, I., Scarselli, M., et al. (2016). Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined. Proc. Natl. Acad. Sci. U.S.A. 113, 2714-2719. doi: 10.1073/pnas.1521142113
12. Blom, A. M., Hallström, T., and Riesbeck, K. (2009). Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol. Immunol. 46, 2808-2817. doi: 10.1016/j.molimm.2009.04.025
13. Blom, A. M., Webb, J., Villoutreix, B. O., and Dahlbäck, B. (1999). A cluster of positively charged amino acids in the C4BP a-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274, 19237-19245. doi: 10.1074/jbc.274.27.19237
14. Boyd, N. A., Bradwell, A. R., and Thompson, R. A. (1993). Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice. J. Clin. Pathol. 46, 1042-1045. doi: 10.1136/jcp.46.11.1042
15. Brangulis, K., Petrovskis, I., Kazaks, A., Akopjana, I., and Tars, K. (2015). Crystal structures of the Erp protein family members ErpP and ErpC from Borrelia burgdorferi reveal the reason for different affinities for complement regulator factor H. Biochim. Biophys. Acta 1854, 349-355. doi: 10.1016/j.bbapap.2014.12.025
16. Brodbeck, W. G., Liu, D., Sperry, J., Mold, C., and Medof, M. E. (1996). Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J. Immunol. 156, 2528-2533.
17. Brouwer, S., Barnett, T. C., Rivera-Hernandez, T., Rohde, M., and Walker, M. J. (2016). Streptococcus pyogenes adhesion and colonization. FEBS Lett. 590, 3739-3757. doi: 10.1002/1873-3468.12254
18. Brueggemann, A. B., Pai, R., Crook, D. W., and Beall, B. (2007). Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 3:e168. doi: 10.1371/journal.ppat.0030168
19. Bubeck, D. (2014). The making of a macromolecular machine: assembly of the membrane attack complex. Biochemistry 53, 1908-1915. doi: 10.1021/bi500157z
20. Burland, V., Shao, Y., Perna, N. T., Plunkett, G., Blattner, F. R., and Sofia, H. J. (1998). The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res. 26, 4196-4204. doi: 10.1093/nar/26.18.4196
21. Caesar, J. J., Johnson, S., Kraiczy, P., and Lea, S. M. (2013). ErpC, a member of the complement regulator-acquiring family of surface proteins from Borrelia burgdorferi, possesses an architecture previously unseen in this protein family. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 69(Pt 6), 624-628. doi: 10.1107/S1744309113013249
22. Caesar, J. J. E., Lavender, H., Ward, P. N., Exley, R. M., Eaton, J., Chittock, E., et al. (2014). Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility. Elife 3:e04008. doi: 10.7554/eLife.04008
23. Cartwright, K. (2002). Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur. J. Pediatr. 161, 188-195. doi: 10.1007/s00431-001-0907-3
24. Cortes, C., Ohtola, J. A., Saggu, G., and Ferreira, V. P. (2012). Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement. Front. Immunol. 3:412. doi: 10.3389/fimmu.2012.00412
25. Costa, I., Pajon, R., and Granoff, D. M. (2014). Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. MBio 5, e01625-e01614. doi: 10.1128/mBio.01625-14
26. Dahlbäck, B., Smith, C. A., and Müller-Eberhard, H. J. (1983). Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. Proc. Natl. Acad. Sci. U.S.A. 80, 3461-3465. doi: 10.1073/pnas.80.11.3461
27. Dai, S., Rajaram, M. V., Curry, H. M., Leander, R., and Schlesinger, L. S. (2013). Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog. 9:e1003114. doi: 10.1371/journal.ppat.1003114
28. Dave, S., Pangburn, M. K., Pruitt, C., and McDaniel, L. S. (2004). Interaction of human factor H with PspC of Streptococcus pneumoniae. Indian J. Med. Res. 119(Suppl.), 66-73.
29. Davis, A. E. 3rd, and Harrison, R. A. (1982). Structural characterization of factor I mediated cleavage of the third component of complement. Biochemistry 21, 5745-5749. doi: 10.1021/bi00266a003
30. Davis, A. E. 3rd Lu, F., and Mejia, P. (2010). C1 inhibitor, a multi-functional serine protease inhibitor. Thromb. Haemost. 104, 886-893. doi: 10.1160/TH10-01-0073
31. de Gouw, D., Serra, D. O., de Jonge, M. I., Hermans, P. W., Wessels, H. J., Zomer, A., et al. (2014). The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins. Emerg. Microbes Infect. 3:e58. doi: 10.1038/emi.2014.58
32. De Gregorio, E., and Rappuoli, R. (2014). From empiricism to rational design: a personal perspective of the evolution of vaccine development. Nat. Rev. Immunol. 14, 505-514. doi: 10.1038/nri3694
33. Dieudonné-Vatran, A., Krentz, S., Blom, A. M., Meri, S., Henriques-Normark, B., Riesbeck, K., et al. (2009). Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J. Immunol. 182, 7865-7877. doi: 10.4049/jimmunol.0802376
34. Döring, G., Parameswaran, I. G., and Murphy, T. F. (2011). Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol. Rev. 35, 124-146. doi: 10.1111/j.1574-6976.2010.00237.x
35. Drentin, N., Conroy, P., Gunzburg, M. J., Pike, R. N., and Wijeyewickrema, L. C. (2015). Investigation of the mechanism of interaction between Mannose-binding lectin-associated serine protease-2 and complement C4. Mol. Immunol. 67(2 Pt B), 287-293. doi: 10.1016/j.molimm.2015.06.011
36. Ermert, D., and Blom, A. M. (2016). C4b-binding protein: the good, the bad and the deadly. Novel functions of an old friend. Immunol. Lett. 169, 82-92. doi: 10.1016/j.imlet.2015.11.014
37. Farkas, I., Baranyi, L., Ishikawa, Y., Okada, N., Bohata, C., Budai, D., et al. (2002). CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. J. Physiol. 539, 537-545. doi: 10.1113/jphysiol.2001.013381
38. Fernandez, R. C., and Weiss, A. A. (1998). Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol. Lett. 163, 57-63. doi: 10.1111/j.1574-6968.1998.tb13026.x
39. Ferreira, D. M., Darrieux, M., Silva, D. A., Leite, L. C., Ferreira, J. M. Jr., Ho, P. L., et al. (2009). Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16, 636-645. doi: 10.1128/CVI.00395-08
40. Ferreira, V. P., Pangburn, M. K., and Cortés, C. (2010). Complement control protein factor H: the good, the bad, and the inadequate. Mol. Immunol. 47, 2187-2197. doi: 10.1016/j.molimm.2010.05.007
41. Fleury, C., Su, Y. C., Hallström, T., Sandblad, L., Zipfel, P. F., and Riesbeck, K. (2014). Identification of a Haemophilus influenzae factor H-Binding lipoprotein involved in serum resistance. J. Immunol. 192, 5913-5923. doi: 10.4049/jimmunol.1303449
42. Forneris, F., Ricklin, D., Wu, J., Tzekou, A., Wallace, R. S., Lambris, J. D., et al. (2010). Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science 330, 1816-1820. doi: 10.1126/science.1195821
43. Freeley, S., Kemper, C., and Le Friec, G. (2016). The "ins and outs" of complement-driven immune responses. Immunol. Rev. 274, 16-32. doi: 10.1111/imr.12472
44. Friese, M. A., Hellwage, J., Jokiranta, T. S., Meri, S., Müller-Quernheim, H. J., Peter, H. H., et al. (2000). Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Clin. Exp. Immunol. 121, 406-415. doi: 10.1046/j.1365-2249.2000.01285.x
45. Fujita, T., Gigli, I., and Nussenzweig, V. (1978). Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J. Exp. Med. 148, 1044-1051.
46. Gaboriaud, C., Thielens, N. M., Gregory, L. A., Rossi, V., Fontecilla-Camps, J. C., and Arlaud, G. J. (2004). Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol. 25, 368-373. doi: 10.1016/j.it.2004.04.008
47. Gordon, D. L., Kaufman, R. M., Blackmore, T. K., Kwong, J., and Lublin, D. M. (1995). Identification of complement regulatory domains in human factor H. J. Immunol. 155, 348-356.
48. Granoff, D. M., Giuntini, S., Gowans, F. A., Lujan, E., Sharkey, K., and Beernink, P. T. (2016). Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight 1:e88907. doi: 10.1172/jci.insight.88907
49. Griffiths, N. J., Hill, D. J., Borodina, E., Sessions, R. B., Devos, N. I., Feron, C. M., et al. (2011). Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol. Microbiol. 82, 1129-1149. doi: 10.1111/j.1365-2958.2011.07876.x
50. Grosskinsky, S., Schott, M., Brenner, C., Cutler, S. J., Simon, M. M., and Wallich, R. (2010). Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl. Trop. Dis. 4:e698. doi: 10.1371/journal.pntd.0000698
51. Gu, C., Jenkins, S. A., Xue, Q., and Xu, Y. (2012). Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA. J. Immunol. 188, 4421-4431. doi: 10.4049/jimmunol.1102092
52. Hair, P. S., Foley, C. K., Krishna, N. K., Nyalwidhe, J. O., Geoghegan, J. A., Foster, T. J., et al. (2013). Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing. Results Immunol. 3, 114-121. doi: 10.1016/j.rinim.2013.10.004
53. Hair, P. S., Wagner, S. M., Friederich, P. T., Drake, R. R., Nyalwidhe, J. O., and Cunnion, K. M. (2012). Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. Mol. Immunol. 50, 253-261. doi: 10.1016/j.molimm.2012.01.010
54. Hajishengallis, G., and Lambris, J. D. (2016). More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol. Rev. 274, 233-244. doi: 10.1111/imr.12467
55. Hallström, T., Blom, A. M., Zipfel, P. F., and Riesbeck, K. (2009). Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J. Immunol. 183, 2593-2601. doi: 10.4049/jimmunol.0803226
56. Hallström, T., Jarva, H., Riesbeck, K., and Blom, A. M. (2007). Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178, 6359-6366. doi: 10.4049/jimmunol.178.10.6359
57. Hallström, T., Mörgelin, M., Barthel, D., Raguse, M., Kunert, A., Hoffmann, R., et al. (2012). Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen. J. Immunol. 189, 4939-4950. doi: 10.4049/jimmunol.1200386
58. Hallström, T., Siegel, C., Mörgelin, M., Kraiczy, P., Skerka, C., and Zipfel, P. F. (2013). CspA from Borrelia burgdorferi inhibits the terminal complement pathway. Mbio 4:e00481-13. doi: 10.1128/mBio.00481-13
59. Hallström, T., Singh, B., Kraiczy, P., Hammerschmidt, S., Skerka, C., Zipfel, P. F., et al. (2016). Conserved patterns of microbial immune escape: pathogenic microbes of diverse origin target the human terminal complement inhibitor vitronectin via a single common motif. PLoS ONE 11:e0147709. doi: 10.1371/journal.pone.0147709
60. Hallström, T., Trajkovska, E., Forsgren, A., and Riesbeck, K. (2006). Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J. Immunol. 177, 430-436. doi: 10.4049/jimmunol.177.1.430
61. Hallström, T., Uhde, M., Singh, B., Skerka, C., Riesbeck, K., and Zipfel, P. F. (2015). Pseudomonas aeruginosa uses dihydrolipoamide dehydrogenase (Lpd) to bind to the human terminal pathway regulators vitronectin and clusterin to inhibit terminal pathway complement attack. PLoS ONE 10:e0137630. doi: 10.1371/journal.pone.0137630
62. Hallström, T., Zipfel, P. F., Blom, A. M., Lauer, N., Forsgren, A., and Riesbeck, K. (2008). Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181, 537-545. doi: 10.4049/jimmunol.181.1.537
63. Hansen, S., Selman, L., Palaniyar, N., Ziegler, K., Brandt, J., Kliem, A., et al. (2010). Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J. Immunol. 185, 6096-6104. doi: 10.4049/jimmunol.1002185
64. Harboe, M., and Mollnes, T. E. (2008). The alternative complement pathway revisited. J. Cell. Mol. Med. 12, 1074-1084. doi: 10.1111/j.1582-4934.2008.00350.x
65. Harboe, M., Ulvund, G., Vien, L., Fung, M., and Mollnes, T. E. (2004). The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138, 439-446. doi: 10.1111/j.1365-2249.2004.02627.x
66. Harris, C. L., Abbott, R. J., Smith, R. A., Morgan, B. P., and Lea, S. M. (2005). Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J. Biol. Chem. 280, 2569-2578. doi: 10.1074/jbc.M410179200
67. Harris, C. L., Pettigrew, D. M., Lea, S. M., and Morgan, P. B. (2007). Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay. J. Immunol. 178, 352-359. doi: 10.4049/jimmunol.178.1.352
68. Haupt, K., Reuter, M., van den Elsen, J., Burman, J., Halbich, S., Richter, J., et al. (2008). The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog. 4:e1000250. doi: 10.1371/journal.ppat.1000250
69. Hegerle, N., and Guiso, N. (2014). Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev. Vaccines 13, 1135-1146. doi: 10.1586/14760584.2014.932254
70. Hengge, U. R., Tannapfel, A., Tyring, S. K., Erbel, R., Arendt, G., and Ruzicka, T. (2003). Lyme borreliosis. Lancet Infect. Dis. 3, 489-500. doi: 10.1016/S1473-3099(03)00722-9
71. Herbert, A. P., Makou, E., Chen, Z. A., Kerr, H., Richards, A., Rappsilber, J., et al. (2015). Complement evasion mediated by enhancement of captured factor H: implications for protection of self-surfaces from complement. J. Immunol. 195, 4986-4998. doi: 10.4049/jimmunol.1501388
72. Hill, D. J., Griffiths, N. J., Borodina, E., Andreae, C. A., Sessions, R. B., and Virji, M. (2015). Identification and therapeutic potential of a vitronectin binding region of meningococcal msf. PLoS ONE 10:e0124133. doi: 10.1371/journal.pone.0124133
73. Hill, D. J., Toleman, M. A., Evans, D. J., Villullas, S., Van Alphen, L., and Virji, M. (2001). The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol. Microbiol. 39, 850-862. doi: 10.1046/j.1365-2958.2001.02233.x
74. Ho, D. K., Riva, R., Kirjavainen, V., Jarva, H., Ginström, E., Blom, A. M., et al. (2012). Functional recruitment of the human complement inhibitor C4BP to Yersinia pseudotuberculosis outer membrane protein Ail. J. Immunol. 188, 4450-4459. doi: 10.4049/jimmunol.1103149
75. Ho, D. K., Skurnik, M., Blom, A. M., and Meri, S. (2014). Yersinia pestis Ail recruitment of C4b-binding protein leads to factor I-mediated inactivation of covalently and noncovalently bound C4b. Eur. J. Immunol. 44, 742-751. doi: 10.1002/eji.201343552
76. Hofmeyer, T., Schmelz, S., Degiacomi, M. T., Dal Peraro, M., Daneschdar, M., Scrima, A., et al. (2012). Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein. J. Mol. Biol. 425, 1302-1317. doi: 10.1016/j.jmb.2012.12.017
77. Holers, V. M., Cole, J. L., Lublin, D. M., Seya, T., and Atkinson, J. P. (1985). Human C3b-and C4b-regulatory proteins: a new multi-gene family. Immunol. Today 6, 188-192.
78. Holmskov, U., Thiel, S., and Jensenius, J. C. (2003). COLLECTINS AND FICOLINS: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21, 547-578. doi: 10.1146/annurev.immunol.21.120601.140954
79. Honda-Ogawa, M., Ogawa, T., Terao, Y., Sumitomo, T., Nakata, M., Ikebe, K., et al. (2013). Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J. Biol. Chem. 288, 15854-15864. doi: 10.1074/jbc.M113.469106
80. Horstmann, R. D., Sievertsen, H. J., Knobloch, J., and Fischetti, V. A. (1988). Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. U.S.A. 85, 1657-1661.
81. Hubert, K., Pawlik, M. C., Claus, H., Jarva, H., Meri, S., and Vogel, U. (2012). Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci. PLoS ONE 7:e45132. doi: 10.1371/journal.pone.0045132
82. Huntington, J. A., Read, R. J., and Carrell, R. W. (2000). Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926. doi: 10.1038/35038119
83. Hyams, C., Trzcinski, K., Camberlein, E., Weinberger, D. M., Chimalapati, S., Noursadeghi, M., et al. (2013). Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b. Infect. Immun. 81, 354-363. doi: 10.1128/IAI.00862-12
84. Jongerius, I., Köhl, J., Pandey, M. K., Ruyken, M., van Kessel, K., van Strijp, J. A., et al. (2007). Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204, 2461-2471. doi: 10.1084/jem.20070818
85. Jongerius, I., von Köckritz-Blickwede, M., Horsburgh, M. J., Ruyken, M., Nizet, V., and Rooijakkers, S. H. (2012). Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses. J. Innate Immun. 4, 301-311. doi: 10.1159/000334604
86. Józsi, M., Tortajada, A., Uzonyi, B., Goicoechea de Jorge, E., and Rodríguez de Cordoba, S. (2015). Factor H-related proteins determine complement-activating surfaces. Trends Immunol. 36, 374-384. doi: 10.1016/j.it.2015.04.008
87. Kenedy, M. R., Vuppala, S. R., Siegel, C., Kraiczy, P., and Akins, D. R. (2009). CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect. Immun. 77, 2773-2782. doi: 10.1128/IAI.00318-09
88. Kilgore, P. E., Salim, A. M., Zervos, M. J., and Schmitt, H. J. (2016). Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin. Microbiol. Rev. 29, 449-486. doi: 10.1128/CMR.00083-15
89. Kim, D. D., and Song, W. C. (2006). Membrane complement regulatory proteins. Clin. Immunol. 118, 127-136. doi: 10.1016/j.clim.2005.10.014
90. Kirjavainen, V., Jarva, H., Biedzka-Sarek, M., Blom, A. M., Skurnik, M., and Meri, S. (2008). Yersinia enterocolitica serum resistance proteins YadA and Ail bind the complement regulator C4b-binding protein. PLoS Pathog. 4:e1000140. doi: 10.1371/journal.ppat.1000140
91. Kohler, S., Hallström, T., Singh, B., Riesbeck, K., Spartà, G., Zipfel, P. F., et al. (2014). Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3. Thromb. Haemost. 113, 125-142. doi: 10.1160/TH14-06-0561
92. Kolodziejek, A. M., Hovde, C. J., and Minnich, S. A. (2012). Yersinia pestis Ail: multiple roles of a single protein. Front. Cell. Infect. Microbiol. 2:103. doi: 10.3389/fcimb.2012.00103
93. Kraiczy, P., and Würzner, R. (2006). Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol. Immunol. 43, 31-44. doi: 10.1016/j.molimm.2005.06.016
94. Kühn, S., Skerka, C., and Zipfel, P. F. (1995). Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J. Immunol. 155, 5663-5670.
95. Kuipers, K., Daleke-Schermerhorn, M. H., Jong, W. S., ten Hagen-Jongman, C. M., van Opzeeland, F., Simonetti, E., et al. (2015). Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization. Vaccine 33, 2022-2029. doi: 10.1016/j.vaccine.2015.03.010
96. Kuttner-Kondo, L. A., Dybvig, M. P., Mitchell, L. M., Muqim, N., Atkinson, J. P., Medof, M. E., et al. (2003). A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. J. Biol. Chem. 278, 52386-52391. doi: 10.1074/jbc.M304620200
97. Laarman, A., Milder, F., van Strijp, J., and Rooijakkers, S. (2010). Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. J. Mol. Med. 88, 115-120. doi: 10.1007/s00109-009-0572-y
98. Lambris, J. D., Ricklin, D., and Geisbrecht, B. V. (2008). Complement evasion by human pathogens. Nat. Rev. Microbiol. 6, 132-142. doi: 10.1038/nrmicro1824
99. Langereis, J. D., and de Jonge, M. I. (2015). Invasive disease caused by nontypeable Haemophilus influenzae. Emerg. Infect. Dis. 21, 1711-1718. doi: 10.3201/eid2110.150004
100. Langereis, J. D., de Jonge, M. I., and Weiser, J. N. (2014). Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance. Mol. Microbiol. 94, 89-106. doi: 10.1111/mmi.12741
101. Langley, R., Wines, B., Willoughby, N., Basu, I., Proft, T., and Fraser, J. D. (2005). The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J. Immunol. 174, 2926-2933. doi: 10.4049/jimmunol.174.5.2926
102. Lathem, W. W., Bergsbaken, T., and Welch, R. A. (2004). Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. J. Exp. Med. 199, 1077-1087. doi: 10.1084/jem.20030255
103. Lathem, W. W., Grys, T. E., Witowski, S. E., Torres, A. G., Kaper, J. B., Tarr, P. I., et al. (2002). StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 45, 277-288. doi: 10.1046/j.1365-2958.2002.02997.x
104. Laursen, N. S., Gordon, N., Hermans, S., Lorenz, N., Jackson, N., Wines, B., et al. (2010). Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 107, 3681-3686. doi: 10.1073/pnas.0910565107
105. Law, S. K., and Dodds, A. W. (1997). The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Science 6, 263-274.
106. Lewis, L. A., Carter, M., and Ram, S. (2012). The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci. J. Immunol. 188, 5063-5072. doi: 10.4049/jimmunol.1103748
107. Lewis, L. A., Ngampasutadol, J., Wallace, R., Reid, J. E., Vogel, U., and Ram, S. (2010). The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog. 6:e1001027. doi: 10.1371/journal.ppat.1001027
108. Lewis, L. A., Vu, D. M., Vasudhev, S., Shaughnessy, J., Granoff, D. M., and Ram, S. (2013). Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis. Mbio 4, e00339-e00313. doi: 10.1128/mBio.00339-13
109. Liszewski, M. K., Leung, M. K., Hauhart, R., Buller, R. M., Bertram, P., Wang, X., et al. (2006). Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 176, 3725-3734. doi: 10.4049/jimmunol.176.6.3725
110. Locht, C. (2016). Pertussis: where did we go wrong and what can we do about it? J. Infect. 72(Suppl) S34-S40. doi: 10.1016/j.jinf.2016.04.020
111. Lublin, D. M., and Atkinson, J. P. (1989). Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7, 35-58.
112. Lucidarme, J., Comanducci, M., Findlow, J., Gray, S. J., Kaczmarski, E. B., Guiver, M., et al. (2009). Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J. Clin. Microbiol. 47, 3577-3585. doi: 10.1128/JCM.00936-09
113. Madar, M., Bencurova, E., Mlynarcik, P., Almeida, A. M., Soares, R., Bhide, K., et al. (2015). Exploitation of complement regulatory proteins by Borrelia and Francisella. Mol. Biosyst. 11, 1684-1695. doi: 10.1039/C5MB00027K
114. Marr, N., Luu, R. A., and Fernandez, R. C. (2007). Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing. J. Infect. Dis. 195, 585-588. doi: 10.1086/510913
115. Marr, N., Shah, N. R., Lee, R., Kim, E. J., and Fernandez, R. C. (2011). Bordetella pertussis autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance. PLoS ONE 6:e20585. doi: 10.1371/journal.pone.0020585
116. Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Arico, B., et al. (2003). Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197, 789-799. doi: 10.1084/jem.20021911
117. McDonald, J. F., and Nelsestuen, G. L. (1997). Potent inhibition of terminal complement assembly by clusterin: characterization of its Impact on C9 polymerization. Biochemistry 36, 7464-7473.
118. Melvin, J. A., Scheller, E. V., Miller, J. F., and Cotter, P. A. (2014). Bordetella pertussis pathogenesis: current and future challenges. Nat. Rev. Microbiol. 12, 274-288. doi: 10.1038/nrmicro3235
119. Meri, S., Jördens, M., and Jarva, H. (2008). Microbial complement inhibitors as vaccines. Vaccine 26(Suppl. 8), I113-I117. doi: 10.1016/j.vaccine.2008.11.058
120. Meri, T., Amdahl, H., Lehtinen, M. J., Hyvärinen, S., McDowell, J. V., Bhattacharjee, A., et al. (2013). Microbes bind complement inhibitor factor H via a common site. PLoS Pathog. 9:e1003308. doi: 10.1371/journal.ppat.1003308
121. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., and Roumenina, L. T. (2015). Complement system part i-molecular mechanisms of activation and regulation. Front. Immunol. 6:262. doi: 10.3389/fimmu.2015.00262
122. Milis, L., Morris, C. A., Sheehan, M. C., Charlesworth, J. A., and Pussell, B. A. (1993). Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Clin. Exp. Immunol. 92, 114-119. doi: 10.1111/j.1365-2249.1993.tb05956.x
123. Missiakas, D., and Schneewind, O. (2016). Staphylococcus aureus vaccines: deviating from the carol. J. Exp. Med. 213, 1645-1653. doi: 10.1084/jem.20160569
124. Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., and van de Beek, D. (2011). Pathogenesis and pathophysiology of pneumococcal meningitis. Clin. Microbiol. Rev. 24, 557-591. doi: 10.1128/CMR.00008-11
125. Morgan, B. P. (1999). Regulation of the complement membrane attack pathway. Crit. Rev. Immunol. 19, 173-198. doi: 10.1615/CritRevImmunol.v19.i3.10
126. Morris, S. K., Moss, W. J., and Halsey, N. (2008). Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect. Dis. 8, 435-443. doi: 10.1016/S1473-3099(08)70152-X
127. Ngampasutadol, J., Ram, S., Gulati, S., Agarwal, S., Li, C., Visintin, A., et al. (2008). Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J. Immunol. 180, 3426-3435. doi: 10.4049/jimmunol.180.5.3426
128. Okumura, C. Y., and Nizet, V. (2014). Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens. Annu. Rev. Microbiol. 68, 439-458. doi: 10.1146/annurev-micro-092412-155711
129. Pan, X., Yang, Y., and Zhang, J. R. (2014). Molecular basis of host specificity in human pathogenic bacteria. Emerg. Microbes Infect. 3:e23. doi: 10.1038/emi.2014.23
130. Paulsson, M., Singh, B., Al-Jubair, T., Su, Y. C., Høiby, N., and Riesbeck, K. (2015). Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa. J. Cyst. Fibros. 14, 600-607. doi: 10.1016/j.jcf.2015.05.005
131. Pausa, M., Pellis, V., Cinco, M., Giulianini, P. G., Presani, G., Perticarari, S., et al. (2003). Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J. Immunol. 170, 3214-3222. doi: 10.4049/jimmunol.170.6.3214
132. Persson, D. B., Schmitz, N. B., Santiago, C., Zocher, G., Larvie, M., Scheu, U., et al. (2010). Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog 6:e1001122. doi: 10.1371/journal.ppat.1001122
133. Pietikäinen, J., Meri, T., Blom, A. M., and Meri, S. (2010). Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol. Immunol. 47, 1299-1305. doi: 10.1016/j.molimm.2009.11.028
134. Pihlstrom, B. L., Michalowicz, B. S., and Johnson, N. W. (2005). Periodontal diseases. Lancet 366, 1809-1820. doi: 10.1016/S0140-6736(05)67728-8
135. Plotkin, S. A. (2016). Need for a new lyme disease vaccine. N. Engl. J. Med. 375, 911-913. doi: 10.1056/NEJMp1607146
136. Potempa, M., and Potempa, J. (2012). Protease-dependent mechanisms of complement evasion by bacterial pathogens. Biol. Chem. 393, 873-888. doi: 10.1515/hsz-2012-0174
137. Preissner, K. T. (1991). Structure and biological role of vitronectin. Annu. Rev. Cell Biol. 7, 275-310. doi: 10.1146/annurev.cb.07.110191.001423
138. Ramos-Sevillano, E., Urzainqui, A., Campuzano, S., Moscoso, M., González-Camacho, F., Domenech, M., et al. (2015). Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Infect. Immun. 83, 591-603. doi: 10.1128/IAI.02811-14
139. Rappuoli, R., and Medaglini, D. (2014). Big science for vaccine development. Vaccine 32, 4705-4707. doi: 10.1016/j.vaccine.2014.06.071
140. Rawal, N., Rajagopalan, R., and Salvi, V. P. (2009). Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP). Mol. Immunol. 46, 2902-2910. doi: 10.1016/j.molimm.2009.07.006
141. Reilly, B. D., Makrides, S. C., Ford, P. J. Jr Marsh, H. C., and Mold, C. (1994). Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J. Biol. Chem. 269, 7696-7701.
142. Rooijakkers, S. H., Ruyken, M., Roos, A., Daha, M. R., Presanis, J. S., Sim, R. B., et al. (2005). Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6, 920-927. doi: 10.1038/ni1235
143. Rooijakkers, S. H., and van Strijp, J. A. (2007). Bacterial complement evasion. Mol. Immunol. 44, 23-32. doi: 10.1016/j.molimm.2006.06.011
144. Rooijakkers, S. H., Wu, J., Ruyken, M., van Domselaar, R., Planken, K. L., Tzekou, A., et al. (2009). Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 10, 721-727. doi: 10.1038/ni.1756
145. Rosadini, C. V., Ram, S., and Akerley, B. J. (2014). Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways. Infect. Immun. 82, 640-649. doi: 10.1128/IAI.01224-13
146. Rossi, R., Granoff, D. M., and Beernink, P. T. (2013). Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice. Vaccine 31, 5451-5457. doi: 10.1016/j.vaccine.2013.08.099
147. Roversi, P., Johnson, S., Caesar, J. J., McLean, F., Leath, K. J., Tsiftsoglou, S. A., et al. (2011). Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc. Natl. Acad. Sci. U.S.A. 108, 12839-12844. doi: 10.1073/pnas.1102167108
148. Rull, A., Martínez-Bujidos, M., Pérez-Cuellar, M., Pérez, A., Ordóñez-Llanos, J., and Sánchez-Quesada, J. L. (2015). Increased concentration of clusterin/apolipoprotein J (apoJ) in hyperlipemic serum is paradoxically associated with decreased apoJ content in lipoproteins. Atherosclerosis 241, 463-470. doi: 10.1016/j.atherosclerosis.2015.06.003
149. Sa E Cunha, C., Griffiths, N. J., and Virji, M. (2010). Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog. 6:e1000911. doi: 10.1371/journal.ppat.1000911
150. Santolaya, M. E., O'Ryan, M. L., Valenzuela, M. T., Prado, V., Vergara, R., Muñoz, A., et al. (2012). Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 379, 617-624. doi: 10.1016/S0140-6736(11)61713-3
151. Schneider, M. C., Exley, R. M., Ram, S., Sim, R. B., and Tang, C. M. (2007). Interactions between Neisseria meningitidis and the complement system. Trends Microbiol. 15, 233-240. doi: 10.1016/j.tim.2007.03.005
152. Schneider, M. C., Prosser, B. E., Caesar, J. J., Kugelberg, E., Li, S., Zhang, Q., et al. (2009). Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458, 890-893. doi: 10.1038/nature07769
153. Seib, K. L., Scarselli, M., Comanducci, M., Toneatto, D., and Masignani, V. (2015). Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. Expert Rev. Vaccines 14, 841-859. doi: 10.1586/14760584.2015.1016915
154. Serruto, D., Rappuoli, R., Scarselli, M., Gros, P., and van Strijp, J. A. (2010). Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat. Rev. Microbiol. 8, 393-399. doi: 10.1038/nrmicro2366
155. Sharp, J. A., Echague, C. G., Hair, P. S., Ward, M. D., Nyalwidhe, J. O., Geoghegan, J. A., et al. (2012). Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS ONE 7:e38407. doi: 10.1371/journal.pone.0038407
156. Singh, B., Al-Jubair, T., Mörgelin, M., Thunnissen, M. M., and Riesbeck, K. (2013). The unique structure of Haemophilus influenzae protein E reveals multiple binding sites for host factors. Infect. Immun. 81, 801-814. doi: 10.1128/IAI.01111-12
157. Singh, B., Su, Y. C., Al-Jubair, T., Mukherjee, O., Hallström, T., Mörgelin, M., et al. (2014). A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells. Infect. Immun. 82, 2378-2389. doi: 10.1128/IAI.01636-13
158. Smith, B. O., Mallin, R. L., Krych-Goldberg, M., Wang, X., Hauhart, R. E., Bromek, K., et al. (2002). Structure of the C3b Binding Site of CR1 (CD35), the immune adherence receptor. Cell 108, 769-780. doi: 10.1016/S0092-8674(02)00672-4
159. Spitzer, D., Mitchell, L. M., Atkinson, J. P., and Hourcade, D. E. (2007). Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol. 179, 2600-2608. doi: 10.4049/jimmunol.179.4.2600
160. Stranger-Jones, Y. K., Bae, T., and Schneewind, O. (2006). Vaccine assembly from surface proteins of Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 103, 16942-16947. doi: 10.1073/pnas.0606863103
161. Su, Y.-C., Jalalvand, F., Mörgelin, M., Blom, A. M., Singh, B., and Riesbeck, K. (2013). Haemophilus influenzae acquires vitronectin via the ubiquitous Protein F to subvert host innate immunity. Mol. Microbiol. 87, 1245-1266. doi: 10.1111/mmi.12164
162. Tsao, N., Tsai, W.-H., Lin, Y.-S., Chuang, W.-J., Wang, C.-H., and Kuo, C.-F. (2006). Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Biochem. Biophys. Res. Commun. 339, 779-784. doi: 10.1016/j.bbrc.2005.11.078
163. Tsiftsoglou, S. A., Arnold, J. N., Roversi, P., Crispin, M. D., Radcliffe, C., Lea, S. M., et al. (2006). Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides. Biochim. Biophys. Acta 1764, 1757-1766. doi: 10.1016/j.bbapap.2006.09.007
164. Vandeputte-Rutten, L., Bos, M. P., Tommassen, J., and Gros, P. (2003). Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J. Biol. Chem. 278, 24825-24830. doi: 10.1074/jbc.M302803200
165. van der Pol, L., Stork, M., and van der Ley, P. (2015). Outer membrane vesicles as platform vaccine technology. Biotechnol. J. 10, 1689-1706. doi: 10.1002/biot.201400395
166. von Pawel-Rammingen, U., and Björck, L. (2003). IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr. Opin. Microbiol. 6, 50-55. doi: 10.1016/S1369-5274(03)00003-1
167. Voss, S., Hallström, T., Saleh, M., Burchhardt, G., Pribyl, T., Singh, B., et al. (2013). The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J. Biol. Chem. 288, 15614-15627. doi: 10.1074/jbc.M112.443507
168. Wang, M., Krauss, J. L., Domon, H., Hosur, K. B., Liang, S., Magotti, P., et al. (2010). Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 3:ra11. doi: 10.1126/scisignal.2000697
169. Wickham, S. E., Hotze, E. M., Farrand, A. J., Polekhina, G., Nero, T. L., Tomlinson, S., et al. (2011). Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8a and C9. J. Biol. Chem. 286, 20952-20962. doi: 10.1074/jbc.M111.237446
170. Wilson, M. R., and Easterbrook-Smith, S. B. (2000). Clusterin is a secreted Mammalian chaperone. Trends Biochem. Sci. 25, 95-98. doi: 10.1016/S0968-0004(99)01534-0
171. Wingrove, J. A., DiScipio, R. G., Chen, Z., Potempa, J., Travis, J., and Hugli, T. E. (1992). Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267, 18902-18907.
172. Wong, W. W., Cahill, J. M., Rosen, M. D., Kennedy, C. A., Bonaccio, E. T., Morris, M. J., et al. (1989). Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J. Exp. Med. 169, 847-863. doi: 10.1084/jem.169.3.847
173. Wu, J., Wu, Y.-Q., Ricklin, D., Janssen, B. J., Lambris, J. D., and Gros, P. (2009). Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10, 728-733. doi: 10.1038/ni.1755
174. Zariri, A., van Dijken, H., Hamstra, H. J., van der Flier, M., Vidarsson, G., van Putten, J. P., et al. (2013). Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles. Vaccine 31, 5585-5593. doi: 10.1016/j.vaccine.2013.07.069
175. Ziccardi, R. J., Dahlback, B., and Müller-Eberhard, H. J. (1984). Characterization of the interaction of human C4b-binding protein with physiological ligands. J. Biol. Chem. 259, 13674-13679.